Association of metformin, dipeptidyl dipeptidase-4 inhibitors, and insulin with COVID-19-related hospital outcomes in patients with type 2 diabetes

OBJECTIVE: The effects of diabetes medications on COVID-19 hospitalization outcomes have not been consistent. We sought to determine the effect of metformin, DPP-4 inhibitors (DPP-4i), and insulin on admission to the intensive care unit (ICU), need for assisted ventilation, development of renal insu...

Descripción completa

Detalles Bibliográficos
Autores principales: Obiri-Yeboah, Derrick, Bena, James, Alwakeel, Mahmoud, Buehler, Lauren, Makin, Vinni, Zhou, Keren, Pantalone, Kevin M., Lansang, M. Cecilia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. on behalf of the AACE. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250053/
https://www.ncbi.nlm.nih.gov/pubmed/37301375
http://dx.doi.org/10.1016/j.eprac.2023.06.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250053/
https://www.ncbi.nlm.nih.gov/pubmed/37301375
http://dx.doi.org/10.1016/j.eprac.2023.06.001

Ejemplares similares